Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations

Copyright © 2019 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 208(2019) vom: 20. Nov., Seite 108228
Auteur principal: Maccari, Maria E (Auteur)
Autres auteurs: Speckmann, Carsten, Heeg, Maximilian, Reimer, Antonia, Casetti, Federica, Has, Cristina, Ehl, Stephan, Castro, Carla N
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Case Reports Letter Research Support, Non-U.S. Gov't CARMIL2 Epidermolysis bullosa Immunodeficiency Plectin RLTPR Whole exome sequencing CARMIL1 protein, human plus... Microfilament Proteins PLEC protein, human
Description
Résumé:Copyright © 2019 Elsevier Inc. All rights reserved.
This study reports a patient with severe skin disease in the context of profound immunodeficiency explained by two concomitant genetic diseases caused by two novel homozygous loss-of-function mutations in PLEC1 and CARMIL2. The work provides additional information on the clinical and immunological manifestations of CARMIL2 deficiency and highlights the particular diagnostic and therapeutic challenge represented by the concomitant presence of two rare monogenic disorders
Description:Date Completed 19.05.2020
Date Revised 12.02.2021
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2019.06.004